BIOMARIN PHARMACEUTICAL INC (BMRN) scores 81 out of 100 on boothcheck's 11-model valuation framework. Verdict: Excellent The estimated fair value is 61.97, representing a 8% margin of safety. Quantitative score: 82/100. Qualitative score: 70/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.